NCT03904758View on ClinicalTrials.gov

Extraesophageal Reflux - Feasibility of Measurement of Pepsin in Saliva as a Diagnostic Option

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

November 30, 2021

Study Completion Date

December 31, 2021

Conditions
Extraesophageal Reflux
Interventions
DIAGNOSTIC_TEST

Pepsin in saliva test

The presence of pepsin in the saliva will be tested in both groups of patients.

Trial Locations (1)

70852

University Hospital Ostrava, Ostrava

All Listed Sponsors
lead

University Hospital Ostrava

OTHER

NCT03904758 - Extraesophageal Reflux - Feasibility of Measurement of Pepsin in Saliva as a Diagnostic Option | Biotech Hunter | Biotech Hunter